Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

Healthcare analyst Ellen Andrews, Ph. D, highlights a first-in-the-nation bill that the state passed this year in an effort to control generic drug prices.

Pharmaceutical Strategies Group (“PSG”), an EPIC company, published its 2025 Trends in Drug Benefit Design Report, delivering critical insights into how payers are navigating a rapidly ...

Takeda Pharmaceutical Co., for example, won approval for the $4,450-a-pill multiple myeloma treatment Ninlaro in 2015 after a trial showed it delayed the growth of bone marrow cancer by six months.

Pharmacy benefit managers, the middlemen between drug manufacturers and insurance providers, would face a range of new requirements under a bill heading to Gov. Kim Reynolds' desk. Supporters say ...

Rising drug prices are hammering patients, employers, and insurers. Is there any end in sight? Soaring demand for high-priced weight loss drugs, known as GLP-1s, has worsened affordability issues ...

SPRINGFIELD, Ill. (WAND) — Gov. JB Pritzker hopes lawmakers will pass a plan this spring to lower prescription drug prices. His proposal could prevent pharmacy benefit managers from inflating ...

In July 2023, the United States Food and Drug Administration (FDA) approved lecanemab as a disease-modifying therapy (DMT) to combat early symptomatic AD. Soon thereafter, in July 2024, donanemab ...

Pfizer Inc. (NYSE:PFE), one of the world's largest pharmaceutical companies with a market capitalization of $151.25 billion, finds itself at a critical juncture as it navigates the post-pandemic ...

MA lawmakers send Healey bill to cap some drug costs, regulate pharmacy benefit mangers Sam Drysdale State House News Service 0:05 ...